TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
The American Geriatrics Society has published a case-based framework for clinicians prescribing obesity medications to older adults. It applies the Geriatrics 5Ms and calls for assessing function, nutrition and cognition before treatment, with measures such as resistance training and adequate protein intake.
The American Geriatrics Society (AGS) has released a framework to help clinicians prescribe obesity medications to older adults, addressing concerns about age-related frailty, nutrition and loss of lean muscle. Published in the Journal of the American Geriatrics Society, the case-based guidance applies the Geriatrics 5Ms to obesity treatments, including incretin medicines such as GLP-1 drugs.
The paper, titled Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient-Centered Prescribing, was developed by the AGS Healthy Aging Special Interest Group. It organizes clinical considerations around Mind, Mobility, Medications, Multicomplexity and Matters Most—a framework intended to bring older adults’ function, health conditions and priorities into treatment decisions.
The authors call for clinicians to assess a patient’s functional status, nutritional adequacy and cognitive impairment before starting treatment. They also highlight possible concerns including sarcopenia and frailty, lean muscle loss, malnutrition and dehydration. The report says older adults are underrepresented in clinical trials, limiting how directly trial evidence may apply to this population.
The framework describes pairing medication with measures such as resistance training and adequate dietary protein. For some patients, care may involve a team that includes a registered dietitian, physical therapist, fitness trainer and behavioral health professional. The article presents these as considerations for individualized care, not a single treatment plan for all older adults.
Balancing Weight Treatment With Function
The framework addresses a clinical tension: obesity medicines may offer benefits for weight management, blood sugar control and other health conditions, while older adults may also face age-related risks that affect how treatment should be planned. The authors’ emphasis on muscle, nutrition, hydration and mobility puts those issues alongside weight and metabolic outcomes.
For patients and clinicians, the guidance underscores that decisions may depend on more than a diagnosis or a medication’s expected effect. Functional ability, cognition, other medications, complex health needs and the patient’s own priorities can shape whether treatment is appropriate and what support should accompany it. The framework offers a structured way to raise those considerations, but the source does not report a clinical trial testing whether its use improves outcomes.
Products Worth Considering
BowFlex Results Series SelectTech Adjustable Dumbbells, Pair
Fitbit Versa Smart Watch – Black Aluminum, One Size (S & L Bands Included)
Bowflex SelectTech 840 Adjustable Kettlebell
As an affiliate, we earn on qualifying purchases.
How the Geriatrics 5Ms Apply
The AGS 5Ms are a geriatrics framework organized around Mind, Mobility, Medications, Multicomplexity and Matters Most. In this paper, the authors use those categories to discuss incretin therapy and other obesity medication decisions in older adults. The case-based format is intended to help clinicians apply the framework to practical prescribing questions.
The report says obesity medicines, including GLP-1 medications that act through gut-derived hormonal pathways, have potential benefits, but older adults have been underrepresented in clinical trials. That evidence gap is part of the reason the authors stress individualized assessment rather than assuming findings from other populations apply equally to older patients. The paper was published in the Journal of the American Geriatrics Society in 2026; its DOI is 10.1111/jgs.70769.
“Safe prescribing requires pretreatment assessment of functional status, nutritional adequacy and cognitive impairment.”
— The AGS framework authors, as summarized by Medical Xpress
Evidence Gaps in Older Patients
The source material does not provide trial results showing how well the framework works in practice, nor does it quantify the benefits or risks of particular obesity drugs for older adults. It reports that older people are underrepresented in clinical trials, but does not specify the size of that gap or how evidence varies by medication, age group or health status.
It is also not clear from the report how the framework will be adopted across clinical settings, or which patients would benefit most from team-based care. The paper offers prescribing considerations; it does not establish that every older adult should receive medication, resistance training or the same nutritional support. Individual decisions remain dependent on a clinician’s assessment and the patient’s circumstances and goals.
How Clinicians May Use the Guidance
The paper is available in the Journal of the American Geriatrics Society for clinicians to consult when considering obesity medications for older adults. The next step described in the source is application of its case-based 5Ms approach in patient care, including pretreatment review and consideration of nutrition, exercise and multidisciplinary support where appropriate.
The source does not announce a follow-up study, implementation program or timetable for new evidence. Further research would be needed to clarify medication outcomes in older adults and test whether using this framework changes prescribing decisions or patient health. Until then, the report’s recommendations are guidance for individualized clinical discussion, not a substitute for medical advice from a qualified professional.
Key Questions
What did the American Geriatrics Society release?
The AGS released a case-based framework to help clinicians consider safe, patient-centered prescribing of obesity medications for older adults.
What are the Geriatrics 5Ms?
The 5Ms are Mind, Mobility, Medications, Multicomplexity and Matters Most. The paper uses them to organize considerations around obesity medication treatment in older adults.
What should clinicians assess before treatment?
The authors call for assessment of functional status, nutritional adequacy and cognitive impairment, while considering issues such as frailty, muscle loss, malnutrition and dehydration.
Does the framework recommend medication for every older adult?
No. The report describes a way to support individualized prescribing decisions; it does not say every older adult should use obesity medication. Treatment choices should be discussed with a qualified clinician.
Why does the paper call for caution?
The report says older adults are underrepresented in clinical trials and may have age-related concerns, including frailty and loss of lean muscle. It does not quantify the evidence gap or establish outcomes for every medication.
Source: medicalxpress.com
